Any AMG updates. : Does anyone have any... - Advanced Prostate...

Advanced Prostate Cancer

21,425 members26,831 posts

Any AMG updates.

JamesHughs profile image
2 Replies

Does anyone have any updates on the AMG trial(s). There was someone on here a while back who offered some encouraging posts but then nothing. Thanks.

Written by
JamesHughs profile image
JamesHughs
To view profiles and participate in discussions please or .
2 Replies
mypk profile image
mypk

If you meant the AMG-509 trial, they continue to recruit participants for the clinical trial slowly. In the first 2 years after the actual start of the trial, 60 patients received AMG-509. I have no clue how many have received it by now. On one Amgen webpage they wrote that initial data readout is anticipated in H2 2023 for AMG-509.

j-o-h-n profile image
j-o-h-n

This is the latest I can find all other (more current) references have been deleted.

AMG509 Trial Experience

Javelin18 profile image

Javelin18•

1 year ago•4 Replies

There's a scheduling delay with the next cohort of the CAR-T trial at City of Hope. I'm going to be discussing whether to wait a bit longer for the CAR-T, or to join the AMG509 BITE trial sooner. I recall some forum members were part of the trial. I'd like to hear about their experience with results and side effects.

Good Luck, Good Health and Good Humor.

j-o-h-n Tuesday 05/23/2023 10:39 PM DST

You may also like...

Advice /Experience with AMG 160

Looking for advice/experience with a trial with AMG 160, does anyone have any feedback on their...

AMG 509 clinical trial

Does anyone here have any info about or perhaps have participated in the Phase I clinical trial of...

Early Readout on Xaluritamig (Amg 509)

d.com/advanced-prostate-cancer/posts/148369124/amg-509-clinical-trial His experience seemed at odds

AMG 509 and CC-94676 Clinical Trials

clinical trial? What side effects have you experienced? Were positive results achieved? Does...

promising against soft tissue and bone metastasis: AMG 509

t-prostate-cancer-mcrpc-interim-results-phase-1-amg-509-xaluritamig.html